| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0764166B1 Corticotropin releasing factor antagonists |
| 09/13/2000 | EP0586570B1 Backbone modified oligonucleotide analogues |
| 09/13/2000 | CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response |
| 09/13/2000 | CN1266434A 1,2,4-triazolo [4,3-B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them |
| 09/13/2000 | CN1266432A Bispyrido-cyclohepatne compounds useful for inhibition of farnesyl protein transferase |
| 09/13/2000 | CN1266423A 1-amino-alkylcyclohexane NMDA receptor antagonists |
| 09/13/2000 | CN1266054A Aryl carboxylic acid and tetrazole derivant |
| 09/13/2000 | CN1265920A Medicinal composition containing cyclosporin |
| 09/13/2000 | CN1265888A Medicinal preparations of anti-allergic reaction compound chromonatohydroxypropyl sodium |
| 09/13/2000 | CN1056373C Process for preparation of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 09/13/2000 | CN1056313C Functional oral liquid for enhancing human immunity |
| 09/13/2000 | CN1056286C Traditional Chinese medicine ointment for treating AIDS |
| 09/12/2000 | US6118001 Anticancer agent; antiarthritic agent |
| 09/12/2000 | US6117998 A1 adenosine receptor antagonists |
| 09/12/2000 | US6117989 Human calcium-binding proteins |
| 09/12/2000 | US6117982 Microbead coupled with binding molecules which lack fc portions and are specific for cd2, cd3 or other t cell receptor-linked components, cd4, cd5 or cd8; anticarcinogenic agents and treatment of infections |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 09/12/2000 | US6117895 Dialkoxyphenyl-substituted oxazolidinones |
| 09/12/2000 | US6117887 Inhibition of 26S and 20S proteasome by indanones |
| 09/12/2000 | US6117874 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4 ) antagonists |
| 09/12/2000 | US6117864 Methods employing stable preparation containing azelastine hydrochloride |
| 09/12/2000 | US6117849 S-(+)-adenosylmethionine and 3'-azido-2', 3'-dideoxy-nucleoside complexes as potent inhibitors of HIV-replication |
| 09/12/2000 | US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents |
| 09/12/2000 | US6117445 Administration of an a1 adenosine receptor antagonist, or p2x purinoceptor or a compination of both offer potential as an antifibrotic or antisclerotic treatment |
| 09/12/2000 | US6117427 Administering immunogenic protein-alkaloid conjugate having indolo(4,3-fg)quinoline derivative |
| 09/12/2000 | US6117421 Method for promoting cell growth and immunosuppression using chaperonin |
| 09/08/2000 | WO2000052055A1 SPECIFIC EGG YOLK ANTIBODIES IgY, THE OBTAINMENT AND USE THEREOF |
| 09/08/2000 | WO2000052041A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000051998A1 Compounds useful as reversible inhibitors of cathepsin s |
| 09/08/2000 | WO2000051636A1 Modulators of fgl2 prothrombinase |
| 09/08/2000 | WO2000051635A2 Emulsan and emulsan analogs immunization formulations and use |
| 09/08/2000 | WO2000051634A1 Vaccine preparations containing fatty acids as constituent |
| 09/08/2000 | WO2000051630A2 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 09/08/2000 | WO2000051605A1 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids |
| 09/08/2000 | WO2000051601A1 Immunopotentiators |
| 09/08/2000 | WO2000051580A2 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 09/08/2000 | WO2000051576A2 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 09/08/2000 | WO2000051432A1 Vaccines and gene therapy compositions and methods of making and using the same |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000023592B1 Minimal promoters and uses thereof |
| 09/08/2000 | WO2000021547A3 Utilization of proteolytic enzymes to influence hyperactive t cells |
| 09/08/2000 | WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 09/08/2000 | WO2000009709A3 Proteases and associated proteins |
| 09/08/2000 | WO1999064595A9 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME |
| 09/08/2000 | CA2366318A1 Novel pharmaceutical, dietary and cosmetic compositions comprising zinger officinale roscoe, eicosapentaenoic acid and/or docosahexaenoic acid |
| 09/08/2000 | CA2364279A1 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 09/08/2000 | CA2362873A1 Vaccines and gene therapy compositions and methods of making and using the same |
| 09/08/2000 | CA2362566A1 Modulators of fgl2 prothrombinase |
| 09/08/2000 | CA2360740A1 Compounds useful as reversible inhibitors of cathepsin s |
| 09/06/2000 | EP1033369A1 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 09/06/2000 | EP1033136A1 The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |
| 09/06/2000 | EP1033128A2 Soft gelatin capsule manufacture |
| 09/06/2000 | EP1032838A1 125 human secreted proteins |
| 09/06/2000 | EP1032674A2 $i(CHLAMYDIA PNEUMONIAE) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032671A1 Mammalian cytokine-like polypeptide-10 |
| 09/06/2000 | EP1032670A1 Toso |
| 09/06/2000 | EP1032669A2 Recombinant allergen with reduced enzymatic activity |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032662A1 Methods and compositions for immunomodulation |
| 09/06/2000 | EP1032582A1 NOVEL recJ |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032421A1 Monoclonal human natural antibodies |
| 09/06/2000 | EP1032420A1 Immunoglobulin molecules having a synthetic variable region and modified specificity |
| 09/06/2000 | EP1032419A1 Saponin adjuvant composition |
| 09/06/2000 | EP1032417A1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 09/06/2000 | EP1032415A2 Composition for the treatment of allergic conditions having cysteine and serine proteinase inhibitory activity |
| 09/06/2000 | EP1032412A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells |
| 09/06/2000 | EP1032409A1 Herbal extract composition and method with immune-boosting capability |
| 09/06/2000 | EP1032396A1 New composition of matter |
| 09/06/2000 | EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 09/06/2000 | EP1032388A1 Novel metal complexes |
| 09/06/2000 | EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| 09/06/2000 | EP0901379B1 Type-2 chemokine binding proteins and methods of use therefor |
| 09/06/2000 | EP0882066B1 Peptide derivatives |
| 09/06/2000 | EP0631502B1 Lymphocyte activity regulation by hla peptides |
| 09/06/2000 | EP0504388B1 Varicella-zoster virus antigen |
| 09/06/2000 | CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265591A Coumpound |
| 09/06/2000 | CN1265318A Xiancaoteng capsule made of korean epimedium herb, liquorice root and common threewingnut root and its preparation |
| 09/06/2000 | CN1265313A Dermatosis treating medicine |
| 09/06/2000 | CN1056145C Prepn. of 1,3-oxathiolane nucleoside analogue medicine composition |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 09/05/2000 | US6114517 Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules |
| 09/05/2000 | US6114516 Nucleotide sequences coding for variable regions of the αchains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic muses |
| 09/05/2000 | US6114515 PIGRL-1, a member of immunoglobulin gene superfamily |
| 09/05/2000 | US6114389 Use of a pharmaceutically acceptable oxalate derivative for the treatment of skin conditions |
| 09/05/2000 | US6114369 N-methyl-n-(1-(4-fluorobenzyl)benzionidazol-2-yl)-n'-methyl-n-(3,5 -bis(trifluoromethyl)benzylaminocarbonyl)-1,3-propylenediamine hydrochloride, for example; substance p antagonists; antiallergic activity |
| 09/05/2000 | US6114367 Such as 3-(3-cyclopentyloxy-4-methoxy)phenyl-2-isoxazoline-5-hydroxamic acid; treating sepsis, septic shock, inflammatory bowel disease, tuberculosis, graft versus host disease or cachexia associated with aids or cancer in a mammal |
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 09/05/2000 | US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 09/05/2000 | US6114352 Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient |
| 09/05/2000 | US6114346 Treating sleep disorders using desloratadine |